About four years after the case was filed—and against the backdrop of a significantly changed COVID-19 vaccine ...

This ends a drawn out legal battle brought by Genevant and Arbutus against Moderna under a week before the jury trial was set to begin.

By Kamal Choudhury and Blake Brittain March 3 (Reuters) - Moderna has agreed to pay Genevant Sciences, a subsidiary of ...

By Puyaan Singh March 4 (Reuters) - Moderna shares rose 9% on Wednesday after it settled a long-running legal battle over the ...

Moderna will pay US$950-million upfront in July, 2026, with an additional US$1.3-billion contingent on the outcome of a separate legal appeal, while not owing royalties for the technology in its ...

Moderna to pay Genevant and Arbutus $950 million upfront and an additional $1.3 billion contingent upon a favorable resolution of Moderna’s ...

The settlement could go as high as $2.25 billion.

Moderna (MRNA) faces a lawsuit in the U.S. for allegedly infringing patent rights related to the COVID-19 shot developed by ...

A guide to coronavirus vaccination rollout and what you need to know about the authorized vaccines. Some 63.8% of Americans have received both doses of the two-shot Pfizer-BioNTech and Moderna drugs ...

Americans have two options for a new omicron-specific Covid booster shot: Pfizer or Moderna. Which one should you get? The short answer: It mostly depends on what you're eligible for. Stream Los ...